Detalhe da pesquisa
1.
Intraventricular CARv3-TEAM-E T Cells in Recurrent Glioblastoma.
N Engl J Med
; 390(14): 1290-1298, 2024 Apr 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-38477966
2.
Phase 1 study of CAR-37 T cells in patients with relapsed or refractory CD37+ lymphoid malignancies.
Blood
; 2024 May 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-38781564
3.
Safety and efficacy of tisagenlecleucel in primary CNS lymphoma: a phase 1/2 clinical trial.
Blood
; 139(15): 2306-2315, 2022 04 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-35167655
4.
Metabolic parameters predict survival and toxicity in chimeric antigen receptor T-cell therapy-treated relapsed/refractory large B-cell lymphoma.
Hematol Oncol
; 42(1): e3231, 2024 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-37795759
5.
Biomarkers and cardiovascular outcomes in chimeric antigen receptor T-cell therapy recipients.
Eur Heart J
; 44(22): 2029-2042, 2023 Jun 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-36939851
6.
Perception of prognosis, quality of life, and distress in patients receiving chimeric antigen receptor T-cell therapy.
Cancer
; 129(3): 441-449, 2023 02 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36457279
7.
Clinical efficacy and safety of chimeric antigen receptor T-cell therapy for mantle cell lymphoma with secondary central nervous system involvement.
Br J Haematol
; 203(5): 774-780, 2023 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-37584155
8.
Efficacy of Tocilizumab in Patients Hospitalized with Covid-19.
N Engl J Med
; 383(24): 2333-2344, 2020 12 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-33085857
9.
A rapid genotyping panel for detection of primary central nervous system lymphoma.
Blood
; 138(5): 382-386, 2021 08 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-33735913
10.
Salvage radiotherapy in relapsed/refractory large B-cell lymphoma after failure of CAR T-cell therapy.
Haematologica
; 108(11): 2972-2981, 2023 11 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-37317884
11.
False-Positive Human Immunodeficiency Virus Test Results in Patients Receiving Lentivirus-Based Chimeric Antigen Receptor T-Cell Therapy: Case Report, Review of the Literature, and Proposed Recommendations.
J Infect Dis
; 225(11): 1933-1936, 2022 06 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34927686
12.
Clinical Perspective: Treatment of Aggressive B Cell Lymphomas with FDA-Approved CAR-T Cell Therapies.
Mol Ther
; 29(2): 433-441, 2021 02 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-33130313
13.
Immunomodulation as Treatment for Severe Coronavirus Disease 2019: A Systematic Review of Current Modalities and Future Directions.
Clin Infect Dis
; 72(12): e1130-e1143, 2021 06 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-33216852
14.
Genome-edited, donor-derived allogeneic anti-CD19 chimeric antigen receptor T cells in paediatric and adult B-cell acute lymphoblastic leukaemia: results of two phase 1 studies.
Lancet
; 396(10266): 1885-1894, 2020 12 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-33308471
15.
Hypoxemic Respiratory Failure Following Ruxolitinib Discontinuation in Allogeneic Hematopoietic Cell Transplantation Recipients.
Oncologist
; 26(11): e2082-e2085, 2021 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-34272781
16.
Two years later: CD19 CAR-T going the distance.
Blood
; 143(5): 379-380, 2024 Feb 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-38300610
17.
Tisagenlecleucel CAR T-cell therapy in secondary CNS lymphoma.
Blood
; 134(11): 860-866, 2019 09 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-31320380
18.
Clinical presentation, management, and biomarkers of neurotoxicity after adoptive immunotherapy with CAR T cells.
Blood
; 133(20): 2212-2221, 2019 05 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-30808634
19.
Healthcare Utilization and End-of-Life Outcomes in Patients Receiving CAR T-Cell Therapy.
J Natl Compr Canc Netw
; 19(8): 928-934, 2021 03 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-33706257
20.
Acute Kidney Injury and Electrolyte Abnormalities After Chimeric Antigen Receptor T-Cell (CAR-T) Therapy for Diffuse Large B-Cell Lymphoma.
Am J Kidney Dis
; 76(1): 63-71, 2020 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-31973908